연구동향 분석

알츠하이머병과 영양 생체지표

강희주(Hee Ju Kang) 홍종우(Jong Woo Hong) 한지원(Ji Won Han) 양수진(Soo-Jin Yang) 김성완(Sung-Wan Kim) 신일선(Il-Seon Shin) 김기웅(Ki Woong Kim) 윤진상(Jin-Sang Yoon) 김재민(Jae-Min Kim) 2014년

논문상세정보
인용/피인용
' 알츠하이머병과 영양 생체지표' 의 주제별 논문영향력
논문영향력 선정 방법
논문영향력 요약
주제
  • 내과학
  • alzheimer disease
  • biomarker
  • dementia
  • diagnosis
  • nutritionalbiomarker
  • 생체지표
  • 알츠하이머 병
  • 영양생체지표
  • 진단
  • 치매
동일주제 총논문수 논문피인용 총횟수 주제별 논문영향력의 평균
3,195 0

0.0%

' 알츠하이머병과 영양 생체지표' 의 참고문헌

  • peripheral abeta subspecies as risk biomarkers of Alzheimer’s disease
    Schupf N Proc Natl Acad Sci USA 105 : 14052 ~ 14057 [2008]
  • n-3 Fatty acid erythrocyte membrane content, APOE varepsilon4, and cognitive variation: an observational follow-up study in late adulthood
    Whalley LJ Am J Clin Nutr 87 : 449 ~ 454 [2008]
  • Zinc-induced apoptosis in substantia nigra of rat brain : neuroprotection by vitamin D3
    Lin AM Free Radic Biol Med 34 : 1416 ~ 1425 [2003]
  • Vitamin D2 potentiates axon regeneration
    Chabas JF J Neurotrauma 25 : 1247 ~ 1256 [2008]
  • Vitamin D, cognition, and dementia: a systematic review and meta-analysis
    Balion C Neurology 79 : 1397 ~ 1405 [2012]
  • Vitamin D is Not Associated with Cognitive Status in a Cohort of Very Old Hospitalized Patients
    Graf CE J Alzheimers Dis 42 : S53 ~ S61 [2014]
  • Vitamin D in the elderly : 5 points to remember
    Annweiler C Geriatr Psychol Neuropsychiatr Vieil 9 : 259 ~ 267 [2011]
  • Vitamin D deficiency
    Holick MF N Engl J Med 357 : 266 ~ 281 [2007]
  • Vitamin D and the risk of dementia and Alzheimer disease
    Littlejohns TJ Neurology 83 : 920 ~ 928 [2014]
  • Vitamin D and risk of cognitive decline in elderly persons
    Llewellyn DJ Arch Intern Med 170 : 1135 ~ 1141 [2010]
  • Vitamin D and cognitive functioning in the elderly population in Germany
    Breitling LP Exp Gerontol 47 : 122 ~ 127 [2012]
  • Vitamin D and cognitive function and dementia risk in a biracial cohort : the ARIC Brain MRI Study
    Schneider AL Eur J Neurol 21 : 1211 ~ 1218 [2014]
  • Value of CSF beta-amyloid1-42 and tau as predictors of Alzheimer’s disease in patients with mild cognitive impairment
    Hampel H Mol Psychiatry 9 : 705 ~ 710 [2004]
  • Uncharged thioflavin-T derivatives bind to amyloid-beta protein with high affinity and readily enter the brain
    Klunk WE Life Sci 69 : 1471 ~ 1484 [2001]
  • Topographical relationship between beta-amyloid and tau protein epitopes in tanglebearing cells in Alzheimer disease
    Spillantini MG Proc Natl Acad Sci USA 87 : 3952 ~ 3956 [1990]
  • Tin and fatty acids in dementia
    Corrigan FM Prostaglandins Leukot Essent Fatty Acids 43 : 229 ~ 238 [1991]
  • The role of diet in cognitive decline
    Solfrizzi V J Neural Transm 110 : 95 ~ 110 [2003]
  • The potential role of nutritional components in the management of Alzheimer’s Disease
    van der Beek EM Eur J Pharmaco 585 : 197 ~ 207 [2008]
  • The amyloid cascade hypothesis for Alzheimer’s disease : an appraisal for the development of therapeutics
    Karran E Nat Rev Drug Discov 10 : 698 ~ 712 [2011]
  • Tau and Abeta42 in cerebrospinal fluid from healthy adults 21-93 years of age : establishment of reference values
    Sjogren M Clin Chem 47 : 1776 ~ 1781 [2001]
  • Systemic tocopherols and F2-isoprostanes and the risk of Alzheimer’s disease and dementia : A prospective populationbased study
    Sundelof J J Alzheimers Dis 18 : 71 ~ 78 [2009]
  • Simplified Quantification of Pittsburgh Compound B amyloid imaging PET studies : a comparative analysis
    Lopresti BJ J Nucl Med 46 : 1959 ~ 1972 [2005]
  • Serum vitamin D deficiency as a predictor of incident non-Alzheimer dementias : A 7-year longitudinal study
    Annweiler C Dement Geriatr Cogn Disord 32 : 273 ~ 278 [2011]
  • Serum fatty-acid composition and the risk of Alzheimer’s disease : a longitudinal population based study
    Rönnemaa E Eur J Clin Nutr 66 : 885 ~ 890 [2012]
  • Serum 25-Hydroxyvitamin D and Cognitive Decline : A Longitudinal Study among Non-Demented Older Adults
    Perna L Dement Geriatr Cogn Disord 38 : 254 ~ 263 [2014]
  • Rethinking Alzheimer’s disease
    de Mendonca A. Front Neurol 3 : 45 ~ [2012]
  • Relationship of cognitive function with B vitamin status, homocysteine, and tissue factor pathway inhibitor in cognitively impaired elderly: a cross-sectional survey
    Kim G J Alzheimers Dis 33 : 853 ~ 862 [2013]
  • Regional analysis of FDG and PIB-PET images in normal aging, mild cognitive impairment, and Alzheimer’s disease
    Li Y Eur J Nucl Med Mol Imaging 35 : 2169 ~ 2181 [2008]
  • Reduced 25-hydroxyvitamin D and risk of Alzheimer’s disease and vascular dementia
    Afzal S Alzheimers Dement 10 : 296 ~ 302 [2014]
  • Rationale and clinical data supporting nutritional intervention in Alzheimer’s disease
    Engelborghs S Acta Clin Belg 69 : 17 ~ 24 [2014]
  • Prospective study of plasma folate, vitamin B12, and cognitive function and decline
    Kang JH Epidemiology 17 : 650 ~ 657 [2006]
  • Projections of future numbers of dementia cases in Australia with and without prevention
    Jorm AF Aust N Z J Psychiatry 39 : 959 ~ 963 [2005]
  • Prediction of Alzheimer disease in mild cognitive impairment : a prospective study in Taiwan
    Wang PN Neurobiol Aging 27 : 1797 ~ 1806 [2006]
  • Prediction of AD with MRI-based hippocampal volume in mild cognitive impairment
    Jack CR Jr Neurology 52 : 1397 ~ 1403 [1999]
  • Population projections for Korea: 2010-2060(based on the 2010 Census)
    Korea National Statistical Office Korea National Statistical office [2011]
  • Plasma tocopherols and risk of cognitive impairment in an elderly Italian cohort
    Ravaglia G Am J Clin Nutr 87 : 1306 ~ 1313 [2008]
  • Plasma phospholipids identify antecedent memory impairment in older adults
    Mapstone M Nat Med 20 : 415 ~ 418 [2014]
  • Plasma phosphatidylcholine docosahexaenoic acid content and risk of dementia and Alzheimer disease : the Framingham Heart Study
    Schaefer EJ Arch Neurol 63 : 1545 ~ 1550 [2006]
  • Plasma nutrient status of patients with Alzheimer’s disease : Systematic review and meta-analysis
    Lopes da Silva S Alzheimers Dement 10 : 485 ~ 502 [2014]
  • Plasma n-3 fatty acids and the risk of cognitive decline in older adults : the Atherosclerosis Risk in Communities Study
    Beydoun MA Am J Clin Nutr 85 : 1103 ~ 1111 [2007]
  • Plasma folate concentration and cognitive performance : Rotterdam Scan Study
    de Lau LM Am J Clin Nutr 86 : 728 ~ 734 [2007]
  • Plasma fatty acid lipidomics in amnestic mild cognitive impairment and Alzheimer’s disease
    Iuliano L Alzheimers Dis 36 : 545 ~ 553 [2013]
  • Plasma clusterin concentration is associated with longitudinal brain atrophy in mild congnitive impairment
    Thambisetty M Neuroimage 59 : 212 ~ 217 [2012]
  • Plasma carotenoids and tocopherols and cognitive function : A prospective study
    Kang JH Neurobiol Aging 29 : 1394 ~ 1403 [2008]
  • Plasma amyloid beta-protein and C-reactive protein in relation to the rate of progression of Alzheimer disease
    Locascio JJ Arch Neurol 65 : 776 ~ 785 [2008]
  • Plasma F2 isoprostane level and cognitive function over eight years in nondemented older adults : Findings from the Helath ACB study
    Fiocco AJ Prostaglandins Leukot Essent Fatty Acids 84 : 57 ~ 61 [2011]
  • Phases of Aβ-deposition in the human brain and its relevance for the development of AD
    Thal DR Neurology 58 : 1791 ~ 1800 [2002]
  • PET imaging of amyloid deposition in patients with mild cognitive impairment
    Forsberg A Neurobiol Aging 29 : 1456 ~ 1465 [2008]
  • Oxidative stress and Alzheimer disease
    Christen Y Am J Clin Nutr 71 : 621S ~ 629S [2000]
  • Oxidative Stress and Its Clinical Applications in Dementia
    Mao P J Neurodegen Dis 2013 : 15 ~ [2013]
  • Oxidation reactions in Parkinson’s disease
    Olanow CW Neurology 40 (10 Suppl 3) : 32 ~ 37 [1990]
  • Omega3 fatty acids and risk of cognitive impairment and dementia
    Laurin D J Alzheimers Dis 5 : 315 ~ 322 [2003]
  • Omega-3 fatty acids and risk of dementia : the Canadian Study of Health and aging
    Kröger E Am J Clin Nutr 90 : 184 ~ 192 [2009]
  • Nutritional determinants of cognitive aging and dementia
    Morris MC. Proc Nutr Soc 71 : 1 ~ 13 [2012]
  • Nutritional approaches in the risk reduction and management of Alzheimer’s disease
    Mi W Nutrition 29 : 1080 ~ 1089 [2013]
  • Novel MRI techniques in the assessment of dementia
    Teipel SJ Eur J Nucl Med Mol Imaging 35 (suppl 1) : S58 ~ S69 [2008]
  • Neuropathological stageing of Alzheimer-related changes
    Braak H Acta Neuropathol 82 : 239 ~ 259 [1991]
  • Neural mechanisms of ageing and cognitive decline
    Bishop NA Nature 464 : 529 ~ 535 [2010]
  • Modern Nutrition in Health and Disease
    Linschee WG Lea&Febiger : 47 ~ 88 [1994]
  • Midlife homocysteine and late-life dementia in women. A prospective population study
    Zylberstein DE Neurobiol Aging 32 : 380 ~ 386 [2011]
  • Microvascular injury and blood-brain barrier leakage in Alzheimer’s disease
    Zipser BD Neurobiol Aging 28 : 977 ~ 986 [2007]
  • Measurement of phosphorylated tau epitopes in the differential diagnosis of Alzheimer disease : a comparative cerebrospinal fluid study
    Hampel H Arch Gen Psychiatry 61 : 95 ~ 102 [2004]
  • Low vitamin B-12 status and risk of cognitive decline in older adults
    Clarke R Am J Clin Nutr 86 : 1384 ~ 1391 [2007]
  • Low serum cholesteryl ester-docosahexaenoic acid levels in Alzheimer’s disease : a case-control study
    Tully AM Br J Nutr 89 : 483 ~ 489 [2003]
  • Low plasma eicosapentaenoic acid and depressive symptomatology are independent predictors of dementia risk
    Samieri C Am J Clin Nutr 88 : 714 ~ 721 [2008]
  • Low plasma N-3 fatty acids and dementia in older persons: the InCHIANTI study
    Cherubini A J Gerontol A Biol Sci Med Sci 62 : 1120 ~ 1126 [2007]
  • Low folate status is associated with impaired cognitive function and dementia in the Sacramento Area Latino Study on Aging
    Ramos MI Am J Clin Nutr 82 : 1346 ~ 1352 [2005]
  • Longitudinal plasma amyloid beta as a biomarker of Alzheimer’s disease
    Rissman RA J Neural Transm 119 : 843 ~ 850 [2012]
  • Longitudinal assessment of Abeta and cognition in aging and Alzheimer disease
    Villemagne VL Ann Neurol 69 : 181 ~ 192 [2011]
  • Inverse relation between in vivo amyloid imaging load and cerebrospinal fluid Abeta42 in humans
    Fagan AM Ann Neurol 59 : 512 ~ 519 [2006]
  • Inflammatory markers and the risk of Alzheimer disease : the Framingham Study
    Tan ZS Neurology 68 : 1902 ~ 1908 [2007]
  • In vivo amyloid imaging with PET in frontotemporal dementia
    Engler H Eur J Nucl Med Mol Imaging 35 : 100 ~ 106 [2008]
  • Imaging brain amyloid in Alzheimer disease with Pittsburgh Compound-B
    Klunk WE Ann Neurol 55 : 306 ~ 319 [2004]
  • Imaging beta-amyloid burden in aging and dementia
    Rowe CC Neurology 68 : 1718 ~ 1725 [2007]
  • Homocysteine, white matter hyperintensities, and cognition in healthy elderly people
    Dufouil C Ann Neurol 53 : 214 ~ 221 [2003]
  • Homocysteine, folate, and vitamin B-12 and cognitive performance in older Chinese adults: findings from the Singapore Longitudinal Ageing Study
    Feng L Am J Clin Nutr 84 : 1506 ~ 1512 [2006]
  • Homocysteine, antioxidant micronutrients and late onset dementia
    Whalley LJ Eur J Nutr 53 : 277 ~ 285 [2014]
  • Homocysteine, B vitamin status, and cognitive function in the elderly
    Duthie SJ Am J Clin Nutr 75 : 908 ~ 913 [2002]
  • Homocysteine and inflammation: predictors of cognitive decline in older persons?
    van den Kommer TN Neurobiol Aging 31 : 1700 ~ 1709 [2010]
  • Homocysteine and holo-transcobalamin and the risk of dementia and Alzheimer’s disease : a prospective study
    Kivipelto M Eur J Neurol 16 : 808 ~ 813 [2009]
  • Homocysteine and cognitive performance in the Framingham offspring study : age is important
    Elias MF Am J Epidemiol 162 : 644 ~ 653 [2005]
  • Homocysteine and cognitive function in elderly people
    Garcia A CMAJ 171 : 897 ~ 904 [2004]
  • Homocysteine and cognitive decline in healthy elderly
    McCaddon A Dement Geriatr Cogn Disord 12 : 309 ~ 313 [2001]
  • Homocysteine B vitamins, and the incidence of dementia and cognitive impairment: results from the Sacramento Area Latino Study on Aging
    Haan MN Am J Clin Nutr 85 : 511 ~ 517 [2007]
  • Homocysteine : a marker for cognitive performance? A longitudinal follow-up study
    Teunissen CE J Nutr Health Aging 7 : 153 ~ 159 [2003]
  • High plasma levels of vitamin E forms and reduced Alzheimer’s disease risk in advanced age
    Mangialasche F J Alzheimers Dis 20 : 1029 ~ 1037 [2010]
  • High density lipoprotein fatty acids in dementia
    Corrigan FM Prostaglandins Leukot Essent Fatty Acids 58 : 125 ~ 127 [1998]
  • Folate, Vitamin B12, and Homocysteine as Risk Factors for Cognitive Decline in the Elderly
    김재민 PSYCHIATRY INVESTIGATION 5 (1) : 36 ~ 40 [2008]
  • Fluctuations of CSF amyloid-beta levels : implications for a diagnostic and therapeutic biomarker
    Bateman RJ Neurology 68 : 666 ~ 669 [2007]
  • Fatty acid analysis of blood plasma of patients with Alzheimer’s disease, other types of dementia, and cognitive impairment
    Conquer JA Lipids 35 : 1305 ~ 1312 [2000]
  • Evaluation of plasma Abeta(40)and Abeta(42)as predictors of conversion to Alzheimer’s disease in patients with mild cognitive impairment
    Hansson O Neurobiol Aging 31 : 357 ~ 367 [2010]
  • Efficacy of a medical food in mild Alzheimer’s disease: A randomized, controlled trial
    Scheltens P Alzheimers Dement 6 : 1-10.e1 ~ [2010]
  • Efficacy of Souvenaid in mild Alzheimer’s disease: results from a randomized, controlled trial
    Scheltens P J Alzheimers Dis 31 : 225 ~ 236 [2012]
  • Effect of Homocysteine Lowering Treatment on Cognitive Function : A Systematic Review and Meta-Analysis of Randomized Controlled Trials
    Ford AH J Alzheimers Dis 29 : 133 ~ 149 [2012]
  • Education and occupation as proxies for reserve in aMCI converters and AD: FDG-PET evidence
    Garibotto, V Neurology 71 : 1342 ~ 1349 [2008]
  • Distribution of the vitamin D receptor and 1 alpha-hydroxylase in human brain
    Eyles DW Chem Neuroanat 29 : 21 ~ 30 [2005]
  • Differential diagnosis of Alzheimer disease with cerebrospinal fluid levels of tau protein phosphorylated at threonine 231
    Buerger K Arch Neurol 59 : 1267 ~ 1272 [2002]
  • Differences in nutritional status between very mild Alzheimer’s disease patients and healthy controls
    Olde Rikkert MG J Alzheimers Dis 41 : 261 ~ 271 [2014]
  • Dietary intake and cognitive function in a group of elderly people
    Ortega RM Am J Clin Nutr 66 : 803 ~ 809 [1997]
  • Dietary factors and Alzheimer’s disease
    Luchsinger JA Lancet Neurol 3 : 579 ~ 587 [2004]
  • Dietary antioxidants and cognitive function in a population-based sample of older persons-The Rotterdam study
    Jama JW Am J Epidemiol 144 : 275 ~ 280 [1997]
  • Dietary antioxidant intake and cognitive performance in middle-aged adults. The atherosclerosis risk in communities(ARIC) study investigators
    Peacock JM Public Health Nutr 3 : 337 ~ 343 [2000]
  • Dietary and lifestyle guidelines for the prevention of Alzheimer’s disease
    Barnard ND Neurobiol Aging 35 (Suppl 2) : S74 ~ S78 [2014]
  • Diagnostic and statistical manual of mental disorders
    American Psychiatric Association American Psychiatric Association [1968]
  • Core candidate neurochemical and imaging biomarkers of Alzheimer’s disease
    Hampel H Alzheimers Dement 4 : 38 ~ 48 [2008]
  • Consensus report of the Working Group on: Molecular and Biochemical Markers of Alzheimer’s Disease
  • Cognitive functions are not affected by dietary fatty acids in elderly in the Pro. V.A. study population
    Manzato E Aging Clin Exp Res 15 : 83 ~ 86 [2003]
  • Cognitive decline is associated with systemic oxidative stress: The EVA study. Etude du Vieillissement Arteriel
    Berr C J Am Geriatr Soc 48 : 1285 ~ 1291 [2000]
  • Cognitive decline and fatty acid composition of erythrocyte membranese The EVA Study
    Heude B Am J Clin Nutr 77 : 803 ~ 808 [2003]
  • Cholinesterase inhibitor treatment alters the natural history of Alzhemers’s disease
    Lopez OL J Neurol Neurosurg Psychiatry 72 : 310 ~ 314 [2002]
  • Changes in folate, vitamin B12 and homocysteine associated with incident dementia
    Kim JM J Neurol Neurosurg Psychiatry 79 : 864 ~ 868 [2008]
  • Cerebrospinal fluid tau/Aβ42 ratio as a prediction of cognitive decline in nondemented older adults
    Fagan AM Arch Neurol 64 : 343 ~ 349 [2007]
  • Cerebrospinal fluid tau, phospho-tau181 and betaamyloid1-42 in idiopathic normal pressure hydrocephalus: a discrimination from Alzheimer’s disease
    Kapaki EN Eur J Neurol 14 : 168 ~ 173 [2007]
  • Cerebrospinal beta-amyloid(1-42)in early Alzheimer’s disease : association with apolipoprotein E genotype and cognitive decline
    Riemenschneider M Neurosci Lett 284 : 85 ~ 88 [2000]
  • Candidate blood proteome markers of Alzheimer’s disease onset and progression : a systematic review and replication study
    Kiddle SJ J Alzheimers Dis 38 : 515 ~ 531 [2014]
  • CSF tau protein phosphorylated at threonine 231 correlates with cognitive decline in MCI subjects
    Buerger K Neurology 59 : 627 ~ 629 [2002]
  • CSF markers for incipient Alzheimer’s disease
    Blennow K Lancet Neurol 2 : 605 ~ 613 [2003]
  • CSF Aβ42 levels correlate with amyloidneuropathology in a population-based autopsy study
    Strozyk D Neurology 60 : 652 ~ 656 [2003]
  • CSF Abeta42, Tau and phosphorylated Tau, APOE epsilon4 allele and MCI type in progressive MCI
    Herukka SK Neurobiol Aging 28 : 507 ~ 514 [2007]
  • Brain imaging evidence of preclinical Alzheimer’s disease in normal aging
    Jagust W Ann Neurol 59 : 673 ~ 681 [2006]
  • Blood-based protein biomarkers for diagnosis of Alzheimer disease
    Doecke JD Arch Neurol 69 : 1318 ~ 1325 [2012]
  • Blood-based biomarkders of microvascular pathology in Alzheimer’s disease
    Ewers M Exp Gerontol 45 : 75 ~ 79 [2010]
  • Biomarkers of Alzheimer’s disease
    Craig-Schapiro R Neurobiol Dis 35 : 128 ~ 140 [2009]
  • Biomarkers for early detection of Alzheimer disease
    Barber RC. J Am Osteopath Assoc 110 : S10 ~ S15 [2010]
  • Biomarkers and surrogate endpoints: preferred definitions and conceptual framework
    Biomarkers Definitions Working Group Clin Pharmacol Ther 69 : 89 ~ 95 [2001]
  • Biochemistry and molecular biology of tauopathies
    Hasegawa M Neuropathology 26 : 484 ~ 490 [2006]
  • Beta-amyloid imaging and memory in nondemented individuals : evidence for preclinical Alzheimer disease
    Pike KE Brain 130 : 2837 ~ 2844 [2007]
  • Associations between serum homocysteine, holotranscobalamin, folate and congnition in the elderly: a longitudinal study
    Hooshmand B J Intern Med 27 : 201 ~ 212 [2012]
  • Association between serum 25(OH)vitamin D and the risk of cognitive decline in older women
    Slinin Y J Ge-rontol A Biol Sci Med Sci 67 : 1092 ~ 1098 [2012]
  • Association between antioxidant nutritional indicators and the incidence of dementia : Results from the PAQUID prospective cohort study
    Helmer C Eur J Clin Nutr 57 : 1555 ~ 1561 [2003]
  • Amyloid beta protein deposition in normal aging has the same characteristics as that in Alzheimer’s disease. Predominance of A beta 42(43)and association of A beta 40 with cored plaques
    Fukumoto H Am J Pathol 148 : 259 ~ 265 [1996]
  • Amyloid PET imaging in patients with mild cognitive impairment : a 2-year follow-up study
    Koivunen J Neurology 76 : 1085 ~ 1090 [2011]
  • Alzheimer’s disease: the cholesterol connection
    Puglielli L Nat. Neurosci 6 : 345 ~ 351 [2003]
  • Alzheimer’s Disease International. Dementia: a public health priority
    World Health Organization
  • Alzheimer mechanisms and therapeutic strategies
    Huang Y. Cell 148 : 1204 ~ 1222 [2012]
  • Altered levels of homocysteine and serum natural antioxidants links oxidative damage to Alzheimer’s disease
    Cankurtaran M J Alzheimers Dis 33 : 1051 ~ 1058 [2013]
  • A leaky blood-brain barrier, fibrinogen infiltration and microglial reactivity in inflamed Alzheimer’s disease brain
    Ryu JK J Cell Mol Med 13 : 2911 ~ 2925 [2009]
  • 1,25-dihydroxyvitamin D3 induces nerve growth factor, promotes neurite outgrowth and inhibits mitosis in embryonic rat hippocampal neurons
    Brown J Neurosci Lett 343 : 139 ~ 143 [2003]
  • (18)F-FDG PET database of longitudinally confirmed healthy elderly individuals improves detection ofmild cognitive impairment and Alzheimer’s disease
    Mosconi L J Nucl Med 48 : 1129 ~ 1134 [2007]